2022 Annual Report
From Frontier Technology to Groundbreaking Discoveries
In 2022, technological advancements and scientific talent have propelled our scientific progress to unprecedented heights, generating groundbreaking discoveries and enabling us to explore new frontiers and drive innovation in the biomedical field.
2022 in numbers
71.5%
PUBLICATIONS IN D1 JOURNALS
€31.2M
BUDGET
28
RESEARCH GROUPS
Research
182
SCIENTIFIC PUBLICATIONS
This year, remarkable progress has been made in research into cancer and metastasis, and ageing- and metabolism-related disorders. We also advanced our fundamental understanding of the mechanisms underlying health and disease. Our research has had a great impact both on the scientific community and society at large.
Published in Nature Cancer
Published in Nature Communications
Published in Nature Communications
Scientific projects
€17.5M
EXTERNAL FUNDING
Here are some notable projects that have been awarded funding in 2022 through both competitive and non-competitive calls run by public and private entities. These and other strategic projects have been advanced using state-of-the-art technologies, such as machine learning, artificial intelligence, and single cell-sequencing.
Innovation
6
ACTIVE SPIN-OFFS
Our spin-offs have made significant contributions to the industry, generating important news and advancements. The groundbreaking discoveries made by our research groups have resulted in licensing agreements, patent filings, and the acquisition of competitive international funding.
The Government of Catalonia and the Catalan Foundation for Research and Innovation has awarded IRB Barcelona the “…
Inbiomotion, a spin-off from IRB Barcelona, developed a unique single-gene-based biomarker for the personalised…
People & Talent
469
PROFESSIONALS
Communications & Public Engagement
3,172
Impacts in media
Our scientific discoveries have sparked widespread interest in the media, including specialist and generalist journals, TV and radio programs, and online platforms, thus leading to an unprecedented media impact.
>8K
PEOPLE REACHED THROUGH PUBLIC ENGAGEMENT ACTIVITIES
We have always stood by the significance of public engagement with science. This year we have celebrated 10 years of the Crazy About Biomedicine Programme, which promotes scientific vocations among tomorrow’s leaders.
Fundraising
€2.58M
Raised since the launch of the Metastasis Challenge
The Metastasis Challenge is not just a fundraising campaign but a powerful movement that unites people and organisations in the fight against metastatic cancer. Thanks to the generous support received, we have raised €2.58M to fund groundbreaking research that brings hope to millions of people affected by this devastating disease.